Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.03.2024 | Case report

Inotuzumab-ozogamicin

Sinusoidal obstruction syndrome

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Bailen R, et al. Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy. Frontiers in Immunology 14: 1165759, Jan 2023. Available from: URL: http://doi.org/10.3389/fimmu.2023.1165759 Bailen R, et al. Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy. Frontiers in Immunology 14: 1165759, Jan 2023. Available from: URL: http://​doi.​org/​10.​3389/​fimmu.​2023.​1165759
Metadaten
Titel
Inotuzumab-ozogamicin
Sinusoidal obstruction syndrome
Publikationsdatum
01.03.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-55217-6

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Multiple drugs

Case report

Pegaspargase

Case report

Multiple drugs